コウソミル株式会社

Cosomil is a pharmaceutical company that researches and develops methods for diagnosing early-stage diseases like cancer.

コウソミル株式会社 is active in the medtech space based in Tokyo, Japan.

Profile

"コウソミル株式会社 is a pioneering medtech company focused on researching and developing innovative methods for diagnosing early-stage diseases, particularly cancer. Utilizing cutting-edge enzyme activity imaging technology, コウソミル specializes in the development of early disease diagnostic tools and pharmaceutical support. Their groundbreaking "single-molecule measurement liquid biopsy" enables the precise evaluation of enzyme activity in blood, leading to the creation of highly accurate testing techniques. With a dual focus on early disease diagnostics and pharmaceutical development support, コウソミル is at the forefront of advancing healthcare through their unique technology. By leveraging fluorescent enzyme substrates and microdevices, they aim to contribute to the evolution of healthcare by potentially detecting early pancreatic cancer and other diseases."

As a business in medtech, コウソミル株式会社 is listed here with the public details available about it.

The business is associated with Tokyo, Japan.

It is recorded at the Plug and Play portfolio startup stage.

Website: cosomil.com